US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Psyence Biomedical Ltd

4.42

-0.2100-4.54%

Volume:55.42K

Turnover:245.67K

Market Cap:2.58M

PE:-0.01

High:4.89

Open:4.62

Low:4.24

Close:4.63

Loading ...

Overview Company News Filings

New PBM Legislation Sparks Healthcare Selloff on Wall Street -- Barrons.com

CVS Might Just Be the Last Drugstore Stock. Should It Be Broken Up? -- Barrons.com

Psyence Biomedical executes binding agreements with Optimi Health

Why Walgreens Boots Alliance Soared Today

BRIEF-Psyence Biomed Executes Agreements With Optimi Health

Psyence Biomedical Ltd - Optimi to Provide Cmc Support for Psyence's Clinical Trials

THOMSON REUTERS

Psyence Biomedical Ltd - Will Obtain Exclusive Rights to Optimi's Drug Candidate for Treatment Use in Palliative Care Context

THOMSON REUTERS

Psyence Biomed Executes Binding Agreements With Optimi Health Corp.

THOMSON REUTERS

Psyence Biomed Executes Binding Agreements with Optimi Health Corp.

Psyence Group Enters Into Agreements With Its Nasdaq-Listed Associate, Psyence Biomedical, to Settle Outstanding Obligations

THOMSON REUTERS

Wall Street Set to Open Flat Thursday; Initial Jobless Claims Higher Than Expected

MT Newswires Live

Psyence Biomedical Boosts Equity to Meet Nasdaq Rules

Psyence Biomedical Revises Debt-for-Equity Deal

Psyence Biomed Strengthens Position with Valuable Stake and Trials

BRIEF-Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress

Psyence Biomedical issues letter to shareholders

Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress

THOMSON REUTERS

Psyence Biomedical Ltd trading halted, news pending

Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PBM/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":4.42,"timestamp":1747944000000,"preClose":4.63,"halted":0,"volume":55416,"delay":0,"floatShares":543613,"shares":583263,"eps":-612.9833,"marketStatus":"Pre-Mkt","change":-0.21,"latestTime":"05-23 07:04:17 EDT","open":4.62,"high":4.89,"low":4.2438,"amount":245668.0666008,"amplitude":0.139568,"askPrice":5.04,"askSize":100,"bidPrice":4.07,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-612.9833,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1748007000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":4.42,"postHourTrading":{"tag":"盘后","latestPrice":4.6,"preClose":4.42,"latestTime":"18:33 EDT","volume":883,"amount":3838.91,"timestamp":1747953185756},"volumeRatio":0.15951767308530876},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","floatShares":543613,"roa":"-137.78%","roe":"-457.86%","lyrEps":-4692.199211,"volumeRatio":0.15951767308530876,"shares":583263,"dividePrice":0,"high":4.89,"amplitude":0.139568,"preClose":4.63,"low":4.2438,"week52Low":2.9218,"pbRate":"-2.05","week52High":699.1882,"institutionHeld":0.0125,"latestPrice":4.42,"eps":-612.9833,"divideRate":0,"volume":55416,"delay":0,"ttmEps":-612.9833,"open":4.62,"prevYearClose":16.8167,"prevWeekClose":5.2,"prevMonthClose":3.6375,"prevQuarterClose":4.782,"fiveDayClose":4.4218,"twentyDayClose":3.6821,"sixtyDayClose":10.6798},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBM\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490892972","title":"New PBM Legislation Sparks Healthcare Selloff on Wall Street -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2490892972","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490892972?lang=en_us&edition=fundamental","pubTime":"2024-12-12 03:58","pubTimestamp":1733947080,"startTime":"0","endTime":"0","summary":"A new proposal in Congress is adding pressure to the embattled industry of pharmacy-benefit managers, or PBMs, middlemen companies with significant influence in the drug supply chain.Bipartisan legislation introduced Wednesday would prohibit ownership of pharmacies and PBMs under the same roof, and would require companies that currently own both types of businesses to divest the pharmacies within three years.The three largest PBMs are integrated inside UnitedHealth Group, CVS Health, and Cigna Group. Shares of all three companies were down sharply on Wednesday, with declines around 5% for each stock. The broader healthcare sector was falling, as well, even as the rest of the market rallied.Independent pharmacies, however, have argued their reimbursement is at the mercy of competitors, since CVS, UnitedHealth, and Cigna also operate pharmacies.The company added: \"Any policies that would limit our ability to negotiate with drugmakers and pharmacies would ultimately increase the cost of m","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4550","BK4137","HCSG","LU0061475181.USD","LU0208291251.USD","LU0320765489.SGD","BK4504","BK4196","LU0211331839.USD","IE00BZ1G4Q59.USD","LU1699723380.USD","BK4588","LU0289739699.SGD","LU0868494617.USD","IE00BKVL7J92.USD","LU0070302665.USD","BK4585","PBM","CVS","BK4139","LU1059921491.USD","IE00BSNM7G36.USD","UNH","LU1261432733.SGD","LU0072461881.USD","IE00B19Z3B42.SGD","LU1571399168.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0162691827.USD","BK4581","CI","LU0006061336.USD"],"gpt_icon":1},{"id":"2490891792","title":"CVS Might Just Be the Last Drugstore Stock. Should It Be Broken Up? -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2490891792","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490891792?lang=en_us&edition=fundamental","pubTime":"2024-12-12 03:14","pubTimestamp":1733944440,"startTime":"0","endTime":"0","summary":"CVS could wind up as the only pharmacy stock in the U.S. if Walgreens goes private. But the drugstore chain, worth about $66 billion, could also become much smaller in the not-so-distant future.The company's board has been considering a breakup for a few months now. It's also possible the government could force its hand.A bipartisan group of lawmakers plans to call for healthcare conglomerates like CVS to sell their pharmacy benefit manager  businesses, which negotiate price rebates with pharmaceutical companies and often run their own mail-order pharmacies.CVS owns the giant PBM Caremark. Insurers UnitedHealth and Cigna own Caremark rivals Optum and Express Scripts, respectively.Concerns about high drug prices and the possibility for more regulation in Washington have weighed on shares of CVS, Walgreens, and insurers such as UnitedHealth, Humana, Cigna, and Anthem owner Elevance Health. CVS has plunged 34% in 2024. It was down 5% alone on Wednesday.In mid-October, shortly after the CV","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072461881.USD","LU0320765489.SGD","LU0348723411.USD","BK4566","SG9999003800.SGD","LU0211331839.USD","LU0878866978.SGD","HUM","LU1506573853.SGD","LU2237957811.SGD","LU1699723380.USD","LU2362541273.HKD","PBM","LU0238689110.USD","LU0106261372.USD","ELV","LU1093756325.SGD","IE00B19Z3B42.SGD","LU0170899867.USD","LU0256863811.USD","LU0061475181.USD","LU0321505868.SGD","SG9999001077.SGD","LU0882574055.USD","LU1023059063.AUD","LU1670628061.USD","LU2592432038.USD","LU0006061336.USD","LU0061474960.USD","IE00BSNM7G36.USD","BK4581","BK4504","BK4196","CI","LU0345770993.USD","LU0557290698.USD","LU1983299246.USD","LU2362541513.USD","LU0314106906.USD","LU1057294990.SGD","LU1720051017.SGD","LU0068578508.USD","WBA","IE00BKVL7J92.USD","CVS","LU2357305700.SGD","BK4550","LU2237957902.USD","LU2505996681.GBP","BK4154"],"gpt_icon":0},{"id":"2490885400","title":"Psyence Biomedical executes binding agreements with Optimi Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2490885400","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490885400?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:35","pubTimestamp":1733920536,"startTime":"0","endTime":"0","summary":"Psyence Biomedical  announced that it has progressed beyond the previously-announced non-binding Letter of Intent, LOI, and executed binding agreements with Optimi Health Corp. Under the terms of the agreements, Optimi becomes the exclusive supplier of GMP-certified, nature-derived  psilocybin extract for Psyence’s global drug development and commercialization initiatives for FDA-approved uses in the Palliative Care context. Optimi will provide comprehensive Chemistry, Manufacturing, and Control support for regulatory submissions related to Psyence’s clinical trials in Palliative Care and any future Investigational New Drug applications. Psyence will obtain exclusive rights to Optimi’s drug candidate for treatment use in the Palliative Care context.Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks. Psyence Biomedical Boosts Equity to Meet Nasdaq Rules. Psyence Biomed Strength","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XeRvyTOtez7ZtvQGLwHolQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/7a4d5c5979e9a116d16fdb63289bd4e9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XeRvyTOtez7ZtvQGLwHolQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/7a4d5c5979e9a116d16fdb63289bd4e9"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psyence-biomedical-executes-binding-agreements-123536328.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-biomedical-executes-binding-agreements-123536328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PBM","PBMWW"],"gpt_icon":0},{"id":"2490284170","title":"Why Walgreens Boots Alliance Soared Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2490284170","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490284170?lang=en_us&edition=fundamental","pubTime":"2024-12-11 03:04","pubTimestamp":1733857440,"startTime":"0","endTime":"0","summary":"Rumors are that a major private equity firm is circling Walgreens.The stock is down over 60% over the past year and even more from all-time highs.The company has struggled to turn itself around under a new CEO.Shares of Walgreens Boots Alliance  soared 20% on Tuesday, as of 2:35 p.m. ET.The beaten-down retail pharmacy rallied on rumors it might get bought out by a private equity firm. Usually, buyouts happen at a premium to the market stock price, and with shares down 63% on the year and 90% from their highs, there was ample room for a premium over yesterday's closing stock price. Private equity to the rescue?","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F800586%2Fgettyimages-1419247648-1.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F800586%2Fgettyimages-1419247648-1.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/12/10/why-walgreens-boots-alliance-soared-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["PBM","BK4139","BK4588","BK4128","BK4585","LU0321505439.SGD","WBA","LU0321505868.SGD"],"gpt_icon":0},{"id":"2490977130","title":"BRIEF-Psyence Biomed Executes Agreements With Optimi Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2490977130","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490977130?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:52","pubTimestamp":1733835165,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomed Executes Agreements With Optimi HealthDec 10 (Reuters) - Psyence Biomedical PBM.O:PSYENCE BIOMED EXECUTES BINDING AGREEMENTS WITH OPTIMI HEALTH CORP.PSYENCE BIOMEDICAL LTD - OPTIM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2490921200","title":"Psyence Biomedical Ltd - Optimi to Provide Cmc Support for Psyence's Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2490921200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490921200?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:30","pubTimestamp":1733833800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2490409244","title":"Psyence Biomedical Ltd - Will Obtain Exclusive Rights to Optimi's Drug Candidate for Treatment Use in Palliative Care Context","url":"https://stock-news.laohu8.com/highlight/detail?id=2490409244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490409244?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:30","pubTimestamp":1733833800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2490092125","title":"Psyence Biomed Executes Binding Agreements With Optimi Health Corp.","url":"https://stock-news.laohu8.com/highlight/detail?id=2490092125","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490092125?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:30","pubTimestamp":1733833800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2490309720","title":"Psyence Biomed Executes Binding Agreements with Optimi Health Corp.","url":"https://stock-news.laohu8.com/highlight/detail?id=2490309720","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490309720?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:30","pubTimestamp":1733833800,"startTime":"0","endTime":"0","summary":"Psyence Biomed obtains exclusive worldwide supply rights to Optimi’s GMP-certified, nature-derived psilocybin for its drug development and commercialization initiatives in Palliative Care. NEW YORK, Dec. 10, 2024  -- Psyence Biomedical Ltd.   today announced that it has progressed beyond the previously-announced non-binding Letter of Intent  and executed binding agreements with Optimi Health Corp. Under the terms of the agreements, Optimi becomes the exclusive supplier of GMP-certified, nature-derived  psilocybin extract for Psyence’s global drug development and commercialization initiatives for FDA-approved uses in the Palliative Care context.“As we continue to efficiently advance our Phase IIb clinical trial for Adjustment Disorder in Palliative Care, these binding agreements with Optimi ensure that we have a consistent supply of very high quality, nature derived psilocybin for pivotal registrational Phase III studies, commercial production if approved, and potential expansion into n","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NTgIdxqiLMziWZlqTH9KVQ--~B/aD04NTt3PTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/2b362d1b510647247b266a9002bacf8d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NTgIdxqiLMziWZlqTH9KVQ--~B/aD04NTt3PTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/2b362d1b510647247b266a9002bacf8d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-biomed-executes-binding-agreements-123000767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBM","PBMWW"],"gpt_icon":0},{"id":"2489097237","title":"Psyence Group Enters Into Agreements With Its Nasdaq-Listed Associate, Psyence Biomedical, to Settle Outstanding Obligations","url":"https://stock-news.laohu8.com/highlight/detail?id=2489097237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489097237?lang=en_us&edition=fundamental","pubTime":"2024-12-07 00:06","pubTimestamp":1733501182,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nTUA5Q3LQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2489684614","title":"Wall Street Set to Open Flat Thursday; Initial Jobless Claims Higher Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2489684614","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489684614?lang=en_us&edition=fundamental","pubTime":"2024-12-05 22:03","pubTimestamp":1733407389,"startTime":"0","endTime":"0","summary":"US stocks look set to open flat in Thursday's trading session as weekly initial jobless claims rose more than expected.The Dow Jones Industrial Average futures were down 0.06%, S&P 500 futures were of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6d9ee77abdb6df8f7c20896d6074b1b9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRFX","PBM","IE00B19Z4B17.USD","BK4190","BK4094","IE0031619046.USD","CAL","LU0566484027.USD","UPXI","VRNT","BK4183","BK4082","CELC","BK4023","BK4007","BJDX","CYCN","IE00B7SZL793.SGD","TARA","LU1559883803.SGD","IE00B66KJ199.SGD","SRM","BK4139"],"gpt_icon":1},{"id":"2488193823","title":"Psyence Biomedical Boosts Equity to Meet Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2488193823","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488193823?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:58","pubTimestamp":1733317116,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) has released an update. Psyence Biomedical Ltd. has undertaken several strategic financial moves to meet Nasdaq’s equity c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/psyence-biomedical-boosts-equity-to-meet-nasdaq-rules?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/psyence-biomedical-boosts-equity-to-meet-nasdaq-rules?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKPKM429.USD","LU2210149790.SGD","MNQmain","QLD","EQR","SQQQ","BK4139","IE00B64PRP62.GBP","PBM","NQmain","LU2210150020.SGD","IE00BGHQF748.EUR","BK4215","BK4585",".IXIC","NDAQ","QID","BK4588","BK4112","PSQ","IE00B3QW5Z07.USD","TQQQ","LU2095319765.USD"],"gpt_icon":0},{"id":"2488160204","title":"Psyence Biomedical Revises Debt-for-Equity Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2488160204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488160204?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:28","pubTimestamp":1733315327,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) has released an update. Psyence Biomedical Ltd. has amended its debt-for-equity exchange agreement with Newcourt SPAC Spon...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/psyence-biomedical-revises-debt-for-equity-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/psyence-biomedical-revises-debt-for-equity-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139","BK4215","BK4588","EQR","BK4585"],"gpt_icon":0},{"id":"2488496069","title":"Psyence Biomed Strengthens Position with Valuable Stake and Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2488496069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488496069?lang=en_us&edition=fundamental","pubTime":"2024-12-03 22:57","pubTimestamp":1733237830,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) has released an update. Psyence Biomedical has doubled the value of its stake in PsyLabs to approximately $2 million, whil...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/psyence-biomed-strengthens-position-with-valuable-stake-and-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/psyence-biomed-strengthens-position-with-valuable-stake-and-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2488616911","title":"BRIEF-Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2488616911","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488616911?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:42","pubTimestamp":1733229721,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomedical Issues Shareholder Update Highlighting Recent ProgressDec 3 (Reuters) - Psyence Biomedical Ltd PBM.O:PSYENCE BIOMEDICAL ISSUES SHAREHOLDER UPDATE HIGHLIGHTING RECENT PROGRESSSource text: ID:nGNX1RGL3Further company coverage: PBM.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA1KWD0H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2488948914","title":"Psyence Biomedical issues letter to shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2488948914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488948914?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:40","pubTimestamp":1733229640,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) issued the following update to shareholders: “I wanted to take this opportunity to recap the significant progress that we ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-issues-letter-to-shareholders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-issues-letter-to-shareholders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2488919194","title":"Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2488919194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488919194?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:30","pubTimestamp":1733229001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA1KWD0H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2486095002","title":"Psyence Biomedical Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2486095002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486095002?lang=en_us&edition=fundamental","pubTime":"2024-11-26 08:52","pubTimestamp":1732582324,"startTime":"0","endTime":"0","summary":"19:50 EST Psyence Biomedical (PBM) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-ltd-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2486059137","title":"Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?","url":"https://stock-news.laohu8.com/highlight/detail?id=2486059137","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486059137?lang=en_us&edition=fundamental","pubTime":"2024-11-25 16:47","pubTimestamp":1732524420,"startTime":"0","endTime":"0","summary":"Englander increased his hedge fund's stake in one high-yield dividend stock by more than 8x in Q3.There's good, bad, and ugly about the stock the billionaire investor bought.Investors might be better off remaining on the sidelines with this stock for now.CVS Health recently appointed four new members to its board of directors. The appointments came after what CVS called a \"productive engagement\" wi","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F798766%2Fpharmacy-store-customers.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F798766%2Fpharmacy-store-customers.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/11/25/billionaire-israel-englander-bought-this-high-yiel/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4585","US5Y.BOND","BK4581","BK4534","BK4139","US12M.BOND","US3Y.BOND","US6M.BOND","US2Y.BOND","PBM","US7Y.BOND","US10Y.BOND","BK4588","US30Y.BOND","BK4559","VOO"],"gpt_icon":0},{"id":"2486741121","title":"Weekly Roundup on the Cannabis Sector & Psychedelic Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2486741121","media":"Market Exclusive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486741121?lang=en_us&edition=fundamental","pubTime":"2024-11-25 09:44","pubTimestamp":1732499048,"startTime":"0","endTime":"0","summary":"Agrify secured $25.9 million through non-brokered private placement. Cannabis giant StateHouse Holdings’ assets up for sale in record receivership deal. Simply Solventless surpassed guidance and reported robust financial growth in Q3 2024. Decibel reported mixed Q3 financial results amid market adjustments. Psyence Biomedical announced 1-for-75 share consolidation to maintain Nasdaq listing requirements. Agrify chairman and interim CEO, Benjamin Kovler, highlighted the significance of the funding, stating, “This funding is a strong move for Agrify and our shareholders as we were able to raise approximately $26 million in a non-brokered deal . We plan to allocate this capital into opportunities within our circle of competence to benefit stockholders.”The company also provided an update on its pending Seorita brand acquisition, affirming that the deal remains on track to close by the end of the year. Kovler expressed enthusiasm about the opportunities ahead, stating, “The team continues ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/weekly-roundup-cannabis-sector-psychedelic-014408889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","MNQmain","LU1043141123.HKD","BK4007","STHZF","LU0345774631.USD","BK4152","LU0994945656.USD","AGFY","PBM","NNI","BK4166","BK4139","QID","MRC","BK4104","NQmain",".IXIC","SQQQ","LU2238339852.HKD","PBMWW","AUD","QLD","LU0426412945.USD","BK4125","PSQ","LU0426417589.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":100,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"PBM","defaultRemindTime":1746451800000,"type":"split","dateTimestamp":1746417600000,"forFactor":797,"toFactor":100,"ratio":7.97},{"market":"US","date":"2024-11-26","symbol":"PBM","defaultRemindTime":1732631400000,"type":"split","dateTimestamp":1732597200000,"forFactor":75,"toFactor":1,"ratio":75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBM","date":"2025-05-22","current":-0.057961,"percent":0.664495,"low":-8.987173,"twenty":-3.246997,"median":-0.120674,"eighty":-0.040522,"high":-0.010313,"avg":-1.36585,"sd":1.894344,"marketCap":2700507},"quantilePoints":[{"date":"2024-02-09","current":-4.032357,"twenty":-6.238869,"median":-6.072412,"eighty":-4.789887,"marketCap":12687649},{"date":"2024-02-16","current":-2.839339,"twenty":-6.098548,"median":-3.798256,"eighty":-3.119893,"marketCap":8908805},{"date":"2024-02-23","current":-2.317077,"twenty":-5.416526,"median":-3.308726,"eighty":-2.830575,"marketCap":7275145},{"date":"2024-03-01","current":-2.358335,"twenty":-4.411122,"median":-2.857169,"eighty":-2.443954,"marketCap":7364862},{"date":"2024-03-08","current":-5.40272,"twenty":-4.595223,"median":-2.890292,"eighty":-2.448252,"marketCap":17006136},{"date":"2024-03-15","current":-6.789855,"twenty":-5.670597,"median":-3.448439,"eighty":-2.49853,"marketCap":21291147},{"date":"2024-03-22","current":-4.959176,"twenty":-5.522615,"median":-3.851628,"eighty":-2.531651,"marketCap":15533164},{"date":"2024-03-28","current":-5.045126,"twenty":-5.473209,"median":-4.390178,"eighty":-2.58397,"marketCap":15800977},{"date":"2024-04-05","current":-4.43423,"twenty":-5.384879,"median":-4.562142,"eighty":-2.723572,"marketCap":13926285},{"date":"2024-04-12","current":-3.616183,"twenty":-5.308825,"median":-4.386712,"eighty":-2.826193,"marketCap":11169148},{"date":"2024-04-19","current":-2.969424,"twenty":-5.158983,"median":-4.227564,"eighty":-2.846471,"marketCap":9153854},{"date":"2024-04-26","current":-3.634228,"twenty":-5.044947,"median":-3.989124,"eighty":-2.883667,"marketCap":11244136},{"date":"2024-05-03","current":-5.498334,"twenty":-5.135216,"median":-4.022166,"eighty":-2.931227,"marketCap":17006136},{"date":"2024-05-10","current":-4.755664,"twenty":-5.044947,"median":-4.198236,"eighty":-2.950931,"marketCap":14729724},{"date":"2024-05-17","current":-3.914422,"twenty":-5.029183,"median":-4.161003,"eighty":-2.965515,"marketCap":12185499},{"date":"2024-05-24","current":-3.576034,"twenty":-4.995271,"median":-3.989124,"eighty":-2.992841,"marketCap":11063362},{"date":"2024-05-31","current":-3.172702,"twenty":-4.97525,"median":-3.912167,"eighty":-3.056175,"marketCap":9842134},{"date":"2024-06-07","current":-3.011838,"twenty":-4.945403,"median":-3.739796,"eighty":-3.056175,"marketCap":9326593},{"date":"2024-06-14","current":-2.737094,"twenty":-4.890312,"median":-3.704137,"eighty":-2.962909,"marketCap":8436115},{"date":"2024-06-21","current":-2.59705,"twenty":-4.889793,"median":-3.670898,"eighty":-2.901711,"marketCap":8034395},{"date":"2024-06-28","current":-1.423571,"twenty":-4.880728,"median":-3.666452,"eighty":-2.842905,"marketCap":4405526},{"date":"2024-07-05","current":-1.29697,"twenty":-4.844987,"median":-3.634228,"eighty":-2.817429,"marketCap":4038622},{"date":"2024-07-12","current":-1.419038,"twenty":-4.808586,"median":-3.573896,"eighty":-2.622548,"marketCap":4414900},{"date":"2024-07-15","current":-1.341218,"twenty":-4.798002,"median":-3.571758,"eighty":-2.605002,"marketCap":4160477},{"date":"2024-08-02","current":-2.495253,"twenty":-4.787417,"median":-3.567957,"eighty":-2.598476,"marketCap":7638460},{"date":"2024-08-09","current":-2.374588,"twenty":-4.74111,"median":-3.476328,"eighty":-2.509232,"marketCap":7322012},{"date":"2024-08-16","current":-0.189652,"twenty":-4.701156,"median":-3.451094,"eighty":-2.420293,"marketCap":7080967},{"date":"2024-08-23","current":-0.185364,"twenty":-4.666284,"median":-3.259617,"eighty":-2.320199,"marketCap":6969168},{"date":"2024-08-30","current":-0.135409,"twenty":-4.625942,"median":-3.217804,"eighty":-1.734415,"marketCap":6927407},{"date":"2024-09-06","current":-0.075064,"twenty":-4.578612,"median":-3.173134,"eighty":-1.374452,"marketCap":3840211},{"date":"2024-09-13","current":-0.0531,"twenty":-4.542825,"median":-3.169013,"eighty":-1.297908,"marketCap":2716532},{"date":"2024-09-20","current":-0.041677,"twenty":-4.46068,"median":-2.990631,"eighty":-0.405342,"marketCap":2132152},{"date":"2024-09-27","current":-0.035704,"twenty":-4.439776,"median":-2.942945,"eighty":-0.186722,"marketCap":1826604},{"date":"2024-10-04","current":-0.033616,"twenty":-4.415223,"median":-2.885007,"eighty":-0.176524,"marketCap":1719746},{"date":"2024-10-11","current":-0.029797,"twenty":-4.335882,"median":-2.827764,"eighty":-0.136917,"marketCap":1524396},{"date":"2024-10-18","current":-0.037238,"twenty":-4.316906,"median":-2.814639,"eighty":-0.115509,"marketCap":1905078},{"date":"2024-10-25","current":-0.030678,"twenty":-4.280698,"median":-2.661,"eighty":-0.061781,"marketCap":1569477},{"date":"2024-10-31","current":-0.030678,"twenty":-4.227564,"median":-2.600616,"eighty":-0.0531,"marketCap":1569477},{"date":"2024-11-08","current":-0.025359,"twenty":-4.168908,"median":-2.560506,"eighty":-0.041677,"marketCap":1297323},{"date":"2024-11-15","current":-0.017624,"twenty":-4.161003,"median":-2.495253,"eighty":-0.039164,"marketCap":901614},{"date":"2024-11-22","current":-0.015339,"twenty":-4.032357,"median":-2.443919,"eighty":-0.0359,"marketCap":784738},{"date":"2024-11-29","current":-0.015056,"twenty":-4.024204,"median":-2.389624,"eighty":-0.035548,"marketCap":770265},{"date":"2024-12-06","current":-0.011488,"twenty":-3.969299,"median":-2.324881,"eighty":-0.03483,"marketCap":587716},{"date":"2024-12-13","current":-0.039719,"twenty":-3.922754,"median":-2.279872,"eighty":-0.03483,"marketCap":2031982},{"date":"2024-12-20","current":-0.047896,"twenty":-3.910815,"median":-1.423571,"eighty":-0.034491,"marketCap":2450332},{"date":"2024-12-27","current":-0.160105,"twenty":-3.826552,"median":-1.380322,"eighty":-0.034771,"marketCap":8190835},{"date":"2025-01-03","current":-0.139339,"twenty":-3.758505,"median":-1.341218,"eighty":-0.034902,"marketCap":7128426},{"date":"2025-01-10","current":-0.109104,"twenty":-3.738121,"median":-1.298666,"eighty":-0.034986,"marketCap":5581651},{"date":"2025-01-17","current":-0.104953,"twenty":-3.725963,"median":-1.286602,"eighty":-0.035261,"marketCap":5369305},{"date":"2025-01-24","current":-0.101395,"twenty":-3.704137,"median":-0.723378,"eighty":-0.035313,"marketCap":5187295},{"date":"2025-01-31","current":-0.153931,"twenty":-3.696057,"median":-0.190404,"eighty":-0.035607,"marketCap":7171947},{"date":"2025-02-07","current":-0.131126,"twenty":-3.670898,"median":-0.185677,"eighty":-0.035672,"marketCap":6109436},{"date":"2025-02-14","current":-0.121624,"twenty":-3.666452,"median":-0.178318,"eighty":-0.035704,"marketCap":5666723},{"date":"2025-02-21","current":-0.130176,"twenty":-3.664547,"median":-0.173585,"eighty":-0.035861,"marketCap":6065165},{"date":"2025-02-28","current":-0.117824,"twenty":-3.640197,"median":-0.162785,"eighty":-0.035996,"marketCap":5489638},{"date":"2025-03-07","current":-0.085527,"twenty":-3.619792,"median":-0.159632,"eighty":-0.03602,"marketCap":3984857},{"date":"2025-03-14","current":-0.072186,"twenty":-3.584064,"median":-0.152664,"eighty":-0.036994,"marketCap":3363289},{"date":"2025-03-21","current":-0.063663,"twenty":-3.572613,"median":-0.146804,"eighty":-0.03763,"marketCap":2966175},{"date":"2025-03-28","current":-0.062237,"twenty":-3.565676,"median":-0.142018,"eighty":-0.03885,"marketCap":2899768},{"date":"2025-04-04","current":-0.055206,"twenty":-3.522789,"median":-0.138728,"eighty":-0.039157,"marketCap":2572161},{"date":"2025-04-11","current":-0.042958,"twenty":-3.483552,"median":-0.135123,"eighty":-0.039608,"marketCap":2001504},{"date":"2025-04-17","current":-0.044165,"twenty":-3.472382,"median":-0.133149,"eighty":-0.040069,"marketCap":2057729},{"date":"2025-04-25","current":-0.043899,"twenty":-3.46015,"median":-0.130176,"eighty":-0.040069,"marketCap":2045333},{"date":"2025-05-02","current":-0.042753,"twenty":-3.450563,"median":-0.129464,"eighty":-0.040303,"marketCap":1991936},{"date":"2025-05-09","current":-0.048509,"twenty":-3.356245,"median":-0.12795,"eighty":-0.040303,"marketCap":2260144},{"date":"2025-05-16","current":-0.055354,"twenty":-3.273683,"median":-0.125425,"eighty":-0.040325,"marketCap":2579043},{"date":"2025-05-22","current":-0.057961,"twenty":-3.246997,"median":-0.120674,"eighty":-0.040522,"marketCap":2700507}],"updateTime":1747998257190}}}